Ambeed.cn

首页 / / / / Zebularine/泽布拉林

Zebularine/泽布拉林 {[allProObj[0].p_purity_real_show]}

货号:A162514 同义名: NSC309132; 4-Deoxyuridine

Zebularine是一种DNA甲基化抑制剂,能够与DNA甲基转移酶形成共价复合物,同时抑制胞苷脱氨酶,Ki值为2 μM。Zebularine诱导大鼠骨髓间充质干细胞 (MSCs) 分化为心肌细胞。

Zebularine/泽布拉林 化学结构 CAS号:3690-10-6
Zebularine/泽布拉林 化学结构
CAS号:3690-10-6
Zebularine/泽布拉林 3D分子结构
CAS号:3690-10-6
Zebularine/泽布拉林 化学结构 CAS号:3690-10-6
Zebularine/泽布拉林 3D分子结构 CAS号:3690-10-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Zebularine/泽布拉林 纯度/质量文件 产品仅供科研

货号:A162514 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 DNA Methyltransferase 其他靶点 纯度
6-Thioguanine 98%
Zebularine 98%
Procainamide HCl 99%
5-Azacytidine 95%
Decitabine 99%
SGI-1027 ++

DNMT3A, IC50: 7.5 μM

DNMT1, IC50: 6 μM

99%+
RG108 +++

DNA methyltransferase, IC50: 115 nM

99%+
Guadecitabine sodium 98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Zebularine/泽布拉林 生物活性

靶点
  • DNA Methyltransferase

描述 The DNA methyltransferase (DNMT) family are enzymes that can mediate the DNA methylation. Inhibiting the DNMTs have shown particular promise in reducing the formation of tumors[6]. Zebularine is a second-generation inhibitor of DNMT with IC50 value of 95 nM on DNMT1[7]. The TFK-1 and HuCCT1 cells were treated with zebularine from 100 - 1000 µM for 72 hours. The cell viability was significantly reduced in a dose dependent manner measured by WST assay. The protein expression level of DNMT1, DNMT3a, DNMT3b examined by western blotting assay was significantly inhibited for both cell lines at concentration of 400 µM and above[8]. BALB/c nude mice with tumor were treated with 10, 50 and 100 mg/kg zebularine via oral gavage in a solution of 0.45% saline every four days for 20 days. The tumor growth was reduced in a dose dependent manner and the cell death in the tumor mass via apoptosis was induced by the treatement of zebularine as measured by the TUNEL assay[9].
作用机制 Zebularine could form tight covalent complexes between the DNMT proteins and zebularine-substitute DNA[10].

Zebularine/泽布拉林 细胞实验

Cell Line
Concentration Treated Time Description References
HaCaT cells 1 μg/mL 48 h To investigate the effect of Zebularine on the proliferation and cytotoxicity of HaCaT cells. Results showed that Zebularine slightly stimulated proliferation at low concentrations (0.1 and 1.0 μg/mL) but inhibited proliferation at higher concentrations. EBioMedicine. 2019 Aug;46:317-329.
46BR.1N cells 1 μg/mL 48 h To investigate the effect of Zebularine on the proliferation and cytotoxicity of 46BR.1N cells. Results showed that Zebularine slightly stimulated proliferation at low concentrations (0.1 and 1.0 μg/mL) but inhibited proliferation at higher concentrations. EBioMedicine. 2019 Aug;46:317-329.
Arabidopsis thaliana cells 20 µM 10 days Screening for mutants sensitive to Zebularine, revealing that SMC6B mutants are highly sensitive to Zebularine Plant Cell. 2023 Apr 20;35(5):1532-1547.
Diabetic LEC 1–20 µM 24 h Zebularine treatment significantly increased Wnt-5a levels and stimulated wound healing in a dose-dependent manner, with a 1.6-fold increase by 24 h. Diabetologia. 2023 Oct;66(10):1943-1958.
HL60 cells 50 or 100 µM 96 h To investigate the effect of Zebularine on HL60 cell differentiation, results showed that Zebularine significantly increased the expression of the CD11b differentiation marker. Cells. 2020 Aug 29;9(9):1991.

Zebularine/泽布拉林 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice Unilateral ureteral obstruction model Intraperitoneal injection 225 mg/kg Once daily for 3 or 7 days Zebularine significantly attenuated renal tubulointerstitial fibrosis and inflammation induced by unilateral ureteral obstruction. Int J Mol Sci. 2022 Nov 14;23(22):14045
BALB/c mice Oral cancer model Oral 1 mg/ml Daily, starting from PID 4 To evaluate the analgesic effect of Zebularine in an oral cancer model, results showed that Zebularine significantly reduced tumor growth and produced mechanical and thermal antinociception. Clin Cancer Res. 2014 Sep 15;20(18):4882-4893
Mice Ear pinna injury model Intraperitoneal injection 1000 mg/kg 7 injections over 10 days To investigate the effect of Zebularine on ear pinna wound regeneration in mice. Results showed that Zebularine significantly promoted ear hole repair, with the mean hole area decreasing by 83.2 ± 9.4% in treated mice compared to 43.6 ± 15.4% in control mice. EBioMedicine. 2019 Aug;46:317-329.
Mice MMTV-PyMT transgenic mice Drinking water 5 mg/mL Daily, for 48 days Zebularine significantly delayed mammary tumor growth, and after 48 days of treatment, the tumors were predominantly necrotic, with a high apoptotic index observed by TUNEL assay as early as 13 days following treatment. Mol Cancer Ther. 2012 Feb;11(2):370-82
Mice Experimental autoimmune uveitis (EAU) model Intraperitoneal injection 10 µg/g Once daily for 7 consecutive days To evaluate the effect of zebularine on intraocular inflammation in EAU mice, results showed that zebularine significantly alleviated intraocular inflammation and retinal tissue damage. Front Immunol. 2019 Aug 16;10:1950

Zebularine/泽布拉林 动物研究

Dose Mice: 500 mg/kg[3] (i.p.); 100 mg/kg[4] (i.v.); 1000 mg/kg[4] (p.o.) Dog: 4 mg/kg, 8 mg/kg[5] (p.o.)
Administration i.p., i.v., p.o.
Pharmacokinetics
Animal Mice[4] Rats[4] Monkeys[4]
Dose 100 mg/kg (i.v.)
1000 mg/kg (p.o.)
50 mg/kg (i.v.)
250 mg/kg (p.o.)
500 mg/kg
Administration i.v.
p.o.
i.v.
p.o.
i.v. or p.o.
F 6.7% (p.o.) 3.1% (p.o.) 0.1% (p.o.)
T1/2 40 min (i.v.) 363 min (i.v.) 70 min (i.v.)
AUC 7323 g/ml·min (i.v.)
4935 g/ml·min (p.o.)
12526 g/ml·min (i.v.)
1969 g/ml·min (p.o.)
88020 g/ml·min (i.v.)
84 g/ml·min (p.o.)
CLapp 203 ml/min/kg (p.o.) 127 ml/min/kg (p.o.) 6021 ml/min/kg (p.o.)
CLtb 13.65 ml/min/kg (i.v.) 3.99 ml/min/kg (i.v.) 5.68 ml/min/kg (i.v.)

Zebularine/泽布拉林 参考文献

[1]Lemaire M, Momparler LF, et al. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine. Cancer Chemother Pharmacol. 2009 Feb;63(3):411-6.

[2]Zhou L, Cheng X, et al. Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol. 2002 Aug 23;321(4):591-9.

[3]Sabatino MA, Geroni C, et al. Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin. Epigenetics. 2013 Jun;8(6):656-65.

[4]Holleran JL, Parise RA, et al. Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine. Clin Cancer Res. 2005 May 15;11(10):3862-8.

[5]Fulkerson CM, Dhawan D, et al. Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs. Vet Comp Oncol. 2017 Mar;15(1):226-236.

[6]Gravina GL, Festuccia C, Marampon F, Popov VM, Pestell RG, Zani BM, Tombolini V. Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation. Mol Cancer. 2010 Nov 25;9:305.

[7]Gros C, Chauvigné L, Poulet A, Menon Y, Ausseil F, Dufau I, Arimondo PB. Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studies. Nucleic Acids Res. 2013 Oct;41(19):e185.

[8]Nakamura K, Nakabayashi K, Htet Aung K, Aizawa K, Hori N, Yamauchi J, Hata K, Tanoue A. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. PLoS One. 2015 Mar 23;10(3):e0120545.

[9]Tan W, Zhou W, Yu HG, Luo HS, Shen L. The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Biochem Biophys Res Commun. 2013 Jan 4;430(1):250-5.

[10]Hurd PJ, Whitmarsh AJ, Baldwin GS, Kelly SM, Waltho JP, Price NC, Connolly BA, Hornby DP. Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone. J Mol Biol. 1999 Feb 19;286(2):389-401.

Zebularine/泽布拉林 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.38mL

0.88mL

0.44mL

21.91mL

4.38mL

2.19mL

43.82mL

8.76mL

4.38mL

Zebularine/泽布拉林 技术信息

CAS号3690-10-6
分子式C9H12N2O5
分子量 228.2
SMILES Code O=C1N=CC=CN1[C@H](O[C@@H]2CO)[C@H](O)[C@@H]2O
MDL No. MFCD04973699
别名 NSC309132; 4-Deoxyuridine; Pyrimidin-2-one beta-ribofuranoside; Pyrimidin-2-one ribonucleoside
运输蓝冰
InChI Key RPQZTTQVRYEKCR-WCTZXXKLSA-N
Pubchem ID 100016
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(460.12 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 50 mg/mL(219.1 mM),配合低频超声助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。